MYER H ROSENTHAL, M.D.
Anesthesiologist Assistant in Palo Alto, CA
License number
California C32509
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
300 Mc 5640, Palo Alto, CA 94305
Phone
(650) 723-7662
Professional information
Myer Hyman Rosenthal, Palo Alto CA
Specialties:
Anesthesiology, Critical Care Medicine, General Practice, Critical Care Medicine, Critical Care Medicine
Work:
Stanford University
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Vermont (1967)
Dr. Myer H Rosenthal, Stanford CA - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine
Address:
Stanford Office
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
Certifications:
Anesthesiology, 1993, Critical Care Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Stanford Office
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of Vermont College Of Medicine
Graduated: 1967
Naval Hospital
Graduated: 1968
Naval Med Center
Graduated: 1970
Graduated: 1971
University Of Vermont College Of Medicine
Graduated: 1967
Naval Hospital
Graduated: 1968
Naval Med Center
Graduated: 1970
Graduated: 1971
Organ Oxygenation State Monitor And Method
US Patent:
2009013, May 28, 2009
Filed:
Nov 28, 2007
Appl. No.:
11/946055
Inventors:
Jason L. Pyle - Redwood City CA, US
Alexander M. Aravanis - San Diego CA, US
Jeffrey N. Roe - San Ramon CA, US
Myer H. Rosenthal - Stanford CA, US
Alexander M. Aravanis - San Diego CA, US
Jeffrey N. Roe - San Ramon CA, US
Myer H. Rosenthal - Stanford CA, US
International Classification:
A61B 5/00
US Classification:
600478
Abstract:
One aspect of the invention provides a patient tissue state monitoring system with a light source; a light detector; a probe adapted to be inserted into a patient to transmit light from the light source to an organ tissue site and to direct light from the organ tissue site to the detector; and a processor programmed to determine tissue state with respect to a tissue site pre-dysoxia point from a fluorescence emission detected by the detector (such as by determining tissue NADH concentration) and to provide an indication of tissue state through an output device (such as by displaying a numerical value corresponding to the fluorescence emission). Another aspect of the invention provides a method of monitoring a patient tissue state including the following steps: monitoring an aerobic energy production level of an organ tissue site (such as tissue within the patient's gastro-intestinal tract, bladder and/or urethra); determining tissue state with respect to a tissue site pre-dysoxia point from the monitored aerobic energy production level; and providing an output of the tissue state (such as by displaying a numerical value corresponding to the fluorescence emission).
System And Method For Monitoring Of End Organ Oxygenation By Measurement Of In Vivo Cellular Energy Status
US Patent:
2007003, Feb 15, 2007
Filed:
Jun 23, 2006
Appl. No.:
11/473976
Inventors:
Jason Pyle - Redwood City CA, US
Alexander Aravanis - San Francisco CA, US
Jeffrey Roe - San Ramon CA, US
Myer Rosenthal - Palo Alto CA, US
Alexander Aravanis - San Francisco CA, US
Jeffrey Roe - San Ramon CA, US
Myer Rosenthal - Palo Alto CA, US
International Classification:
A61B 6/00
US Classification:
600476000
Abstract:
A method is provided of measuring in vivo of an endogenous fluorophore in a tissue site. A known excitation wavelength of the endogenous flurophore is selected within a range of wavelengths at which the endogenous flurophore undergoes fluorescence. The tissue site is irradiated with irradiated light having at least the selected excitation wavelength within the range of wavelengths. A fluorescence emission of the tissue site resulting from the irradiation thereof is detected. A relative or absolute concentration of the endogenous fluorophore is determined by multiplying it by a calibration factor that depends one at least one of, a known excitation and emission property of the endogenous fluorophore, an intensity of the irradiated light, optical properties of an excitation probe, and specific properties of the tissue. The relative or absolute concentration of the endogenous fluorphore is used to estimate at least one of a, in vivo cellular energy production status or state of end-organ tissue oxygenation.